Top compounds associated with response to CT62


Feature Type Standardized
Nominal ANOVA
mRNA AZD-2281 FIMM pan-cancer AAC 0.13 0.4
mRNA Erlotinib GDSC1000 pan-cancer AAC 0.037 0.4
mRNA BRD-K17060750 CTRPv2 pan-cancer AAC -0.029 0.4
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.027 0.4
mRNA BMS-754807 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA itraconazole CTRPv2 pan-cancer AAC -0.029 0.4
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC -0.028 0.4
mRNA Mitomycin-C GDSC1000 pan-cancer AAC -0.027 0.4
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.4
Download CSV